Kuros Biosciences Ltd.
KURN | SIX
Overview
Corporate Details
- ISIN(s):
- CH0325814116
- LEI:
- 5299006U5POB2AVTT709
- Country:
- Switzerland
- Address:
- Wagisstraße 25, 8952 Schlieren
- Website:
- https://kurosbio.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
With more than 150 years of combined research experience, we feel well-established as leaders in orthobiologics, but we're never content with resting on our laurels. Instead, we continue to forge beyond the accepted solutions for spinal fusion. Our focus is on revolutionizing the field of orthobiologics by developing bone grafts that deliver both targeted and controlled bone healing.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-11 01:00 |
Earnings Release
Kuros Biosciences grows sales to CHF 75.6 million for 2024
|
English | 19.2 KB | |
| 2025-01-08 07:00 |
Regulatory News Service
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 13.7 KB | |
| 2025-01-07 07:00 |
Regulatory News Service
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 13.7 KB | |
| 2025-01-07 01:00 |
Regulatory News Service
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 11.8 KB | |
| 2024-11-19 07:00 |
Board/Management Change
Kuros Biosciences Expands into Extremities Markets
|
English | 18.5 KB | |
| 2024-11-19 01:00 |
Board/Management Change
Kuros Biosciences Expands into Extremities Markets
|
English | 16.1 KB | |
| 2024-10-10 02:00 |
Earnings Release
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow brea…
|
English | 16.3 KB | |
| 2024-08-08 07:00 |
Earnings Release
Kuros Biosciences Reports First Half of 2024 Results
|
English | 37.6 KB | |
| 2024-08-08 02:00 |
Earnings Release
Kuros Biosciences Reports First Half of 2024 Results
|
English | 33.0 KB | |
| 2024-06-25 07:00 |
Regulatory News Service
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
|
English | 17.2 KB | |
| 2024-06-25 02:00 |
Regulatory News Service
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
|
English | 14.9 KB | |
| 2024-04-24 07:00 |
Earnings Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct M…
|
English | 17.0 KB | |
| 2024-04-24 02:00 |
Earnings Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct M…
|
English | 14.9 KB | |
| 2024-04-17 14:05 |
Declaration of Voting Results & Voting Rights Announcements
Annual General Meeting of Kuros Biosciences approves all resolutions
|
English | 10.3 KB | |
| 2024-04-17 02:00 |
Declaration of Voting Results & Voting Rights Announcements
Annual General Meeting of Kuros Biosciences approves all resolutions
|
English | 8.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-23 | N/A | Executive member | Sell | None | 1,264,800.00 CHF |
| 2025-04-17 | N/A | Executive member | Sell | None | 13,344.49 CHF |
| 2025-03-18 | N/A | Non-Executive member | Buy | None | 38,200.00 CHF |
| 2024-12-11 | N/A | Executive member | Sell | None | 4,702,500.00 CHF |
| 2024-11-15 | N/A | Non-Executive member | Buy | None | 925,210.00 CHF |
| 2024-11-14 | N/A | Non-Executive member | Sell | None | 592,000.00 CHF |
| 2024-11-12 | N/A | Executive member | Sell | None | 13,890.86 CHF |
| 2024-09-25 | N/A | Executive member | Sell | None | 8,226,000.00 CHF |
| 2024-09-25 | N/A | Non-Executive member | Sell | None | 3,656,000.00 CHF |
| 2024-09-24 | N/A | Non-Executive member | Buy | None | 223,720.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GenSight Biologics S.A. | France | SIGHT | |
|
Gentian Diagnostics ASA | Norway | GENT | |
|
Genus PLC | United Kingdom | GNS | |
|
Grace Breeding Ltd. | Israel | GRAC | |
|
Group 107 Ltd. | Israel | G107 | |
|
Guard Therapeutics International AB | Sweden | GUARD | |
|
Gubra A/S | Denmark | GUBRA | |
|
Hadasit Bio Holding Ltd. | Israel | HDST-M | |
|
Hansa Biopharma | Sweden | HNSA | |
|
HEMOGENYX PHARMACEUTICALS PLC | United Kingdom | HEMO |